RG

Ruby Gogia

Active Director Director DIN 07587798
DIN 07587798 First appointment Sep 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2016
Shareholding value •••• Premium profile

About Ruby Gogia

Data last updated:

Ruby Gogia is a Director at Mediart Lifesciences Private Limited (since 2016). The company operates in Pharma. Mediart Lifesciences Private Limited reported revenue of ₹41.86 Cr (FY 2025).

DIN 07587798
Primary Designation Director
Industry Pharma
First Appointment 03 Sep 2016
Oldest Company Age 11 yrs
Largest company Mediart Lifesciences Private Limited · ₹41.86 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mediart Lifesciences Private Limited U51109DL2015PTC286671
Director03 Sep 20162015₹41.86 Cr (FY 2025)Active

Board colleagues of Ruby Gogia

NameDINCompanyDesignation
Rajesh Kaul07322375Mediart Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mediart Lifesciences Private Limited
Premium access

Shareholding and investment profile for Ruby Gogia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ruby Gogia

Ruby Gogia currently holds 1 directorship: Mediart Lifesciences Private Limited (Director, since 03 Sep 2016, revenue ₹41.86 Cr (FY 2025)).

Ruby Gogia was first appointed on 03 Sep 2016 as Director at Mediart Lifesciences Private Limited.

The current boards of Ruby Gogia's companies include Rajesh Kaul (Mediart Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available